Dunedin company Pacific Edge has two more New Zealand health boards using its bladder cancer diagnostic tool - Cxbladder.
Pacific Edge chief executive David Darling said yesterday urologists at the health boards of Bay of Plenty and Lakes District were the latest to join the growing list of New Zealand clinicians and health boards ''who are being signed by Pacific Edge diagnostics to offer their patients Cxbladder''.
He said patients from both health boards presenting with symptoms of bladder cancer, and those under surveillance of bladder cancer, will now be evaluated as part of their clinical programme.
Mr Darling wanted to clarify Monday's separate announcement, that Pacific Edge had signed an agreement directly with Government commercial entity Health Innovation Hub, which is mandated to get new health technology into four district health boards.
HIH will now negotiate with the health boards of Auckland, Waitemata, Counties-Manukau and Canterbury, covering a population of more than 2.2 million, for the future use of Cxbladder.
